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ust the mention of Kenya conjures up romantic 
images of this beautiful land — the heart of 
African safari country, the cradle of humanity, the 
home of proud warrior tribes, and the survivor of 
colonial oppression. Few of us actually have trav- 
eled to Kenya, most of us have been there only 
in our dreams or through the magic of cinema. 
For a group of St. Louis healthcare professionals, 
going to Kenya became a reality as they journeyed 
to Nairobi to provide medical and educational 
assistance to the patients and staff of Kenyatta 
National Hospital. For more on this story, turn 
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OUTPATIENT CARE IN ONE CONVENIENT LOCATION 
Radiation oncology has moved clinical and physics 
staff into the new Center for Advanced Medicine, a 
collaborative effort between Washington University 
School of Medicine and Barnes-Jewish Hospital to 
provide ambulatory patients with convenient, multi- 
disciplinary care. 
SIFTING THROUGH THE CONFUSION OF 
ALZHEIMER'S DISEASE 
As part of one of the largest National Institutes of 
Health studies on Alzheimer's disease, the collaborative 
efforts of radiologists, neurologists, and psychiatrists 
at Washington University Medical Center may help to 
identify people at risk for developing the progressive, 
degenerative brain disorder. 
RADIOLOGY IN THE CRADLE OF HUMANITY 
Working side-by-side with surgeons at Kenya's largest 
public hospital, a multi-institutional team of St. Louis 
healthcare providers, including a Mallinckrodt Institute 
neuroradiologist, treated patients with brain and spinal 
cord problems and gained a new perspective on the 
practice of medicine. 
TRACING THE ROOTS OF DEPRESSION 
Results of a Mallinckrodt Institute researcher's decade- 
long study of clinical depression show that anomalies in 
the brain's serotonin system play an important role in 
setting the stage for depression, discoveries that can 
impact the treatment not only of this disease but others 
such as Parkinson disease and epilepsy. 
ON THE COVER A face you can never forget. Jim Kelly was one of the patients treated 
at Kenyatta National Hospital (KNH) in Nairobi, Kenya, by the St. Louis Neurosurgical 
Mission team. Inset photo shows David Jeck, MD, an MIR clinical fellow in neuroradiology, 
and Jessica Wabani, MD, chair of radiology at KNH. 
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The radiation oncology 
residents annually select a 
faculty member who has 
made a significant contribu- 
tion to radiation oncology 
resident education during 
the academic year. Joseph 
Simpson, MD, PhD, was 
named the 2001 Radiation 
Oncology Teacher of the 
Year. 
After completing a radi- 
ation oncology residency at 
the University of Wisconsin 
Hospital in Madison, where 
he was chief resident and an 
American Cancer Society 
Clinical Fellow, Simpson 
joined the Mallinckrodt 
Institute faculty in 1978 as 
an assistant professor. He 
serves as clinical chief of the 
Department of Radiation 
Oncology's CNS service. 
A fellow of the Ameri- 
can College of Radiology, 
Simpson is a member of sev- 
eral medical organizations, 
including the American 
Association for Cancer 
Research, the American 
Society for Therapeutic 
Radiology and Oncology, 
and the American Society for 
Clinical Oncology. He is a 
member of the United States 
Department of Defense Dedi- 
cated Breast Cancer Tumor 
Board. 
At Washington Univer- 
sity Medical Center, Simpson 
coordinates the Radiation 
Oncology Summer Oncology 
Program, is coursemaster for 
the Radiation Oncology 
Senior Elective and Radiol- 
ogy Elective, and cochairs 
the Neuro-Oncology Focus 
Group. He has authored and 
coauthored approximately 
100 scientific articles and 
book chapters and serves as 
a peer reviewer for several 
scientific journals, including 
The International Journal 
of Radiation Oncology, 




In recognition of her 
contributions to the field of 
breast imaging, Dione Farria, 
MD, MPH, was elected a fel- 
low of the Society of Breast 
Imaging (SBI) in November. 
The SBI was organized 
in 1985 to improve and dis- 
seminate the scientific, 
professional, and educa- 
tional aspects of breast 
imaging. The Society now 
has 1,520 members and 
79 fellows. Barbara Monsees, 
MD, professor of radiology 
and chief of MIR's breast 
imaging, serves as the 2001 - 
2003 SBI president. 
Farria earned a medical 
degree from Harvard Univer- 
sity and a Masters of Public 
Health degree from Univer- 
sity of California, Los Ange- 
les School of Public Health. 
While at UCLA, she com- 
pleted residencies in 
diagnostic radiology and 
preventive medicine as well 
as a breast imaging clinical 
fellowship and a Robert 
Wood Johnson Clinical 
Scholars Program fellowship 
in health services research 
methodology. Prior to join- 
ing the MIR faculty in 1999, 
Farria was an American 
Roentgen Ray Scholar and 
an assistant professor of 
radiology at Thomas Jeffer- 
son University Hospital in 
Philadelphia, Pennsylvania. 
She is a member of 
Delta Omega National Honor 
Society for public health as 
well as several medical orga- 
nizations, including RSNA, 
the American Association 
of Women Radiologists, and 
the American Roentgen Ray 
Society. Farria currently 
serves on the Continuing 
Education Committee o' 
American College of Pr 
tive Medicine, the Amei 
College of Radiology's C 
mittee on Mammographj 
Interpretive Skills Assess 
ment, and the SBFs Eco- 
nomic and Practice Issues 
Committee. She is a produi - \ 
tive author and coauthor Oi 
scientific and health educa 
tion publications. 







The highly acclaimed 
first edition of Pediatric 
JSonography, authored by 
Marilyn Siegel, MD, was a 
pomprehensive, standard- 
letting reference on the indi- 
:ations, advantages, and 
imitations of pediatric 
ionography. Now in its third 
:dition, the text provides 
ilinicians with a complete 
orking knowledge of the 
st scanning technologies 
he expanding clinical 
ations of ultrasound in 
ric patients, 
iegel, professor of 
iogy and of pediatrics, 
./aized the book's third 
aon into site-specific 
lapters, including scanning 
;chniques, normal sono- 
graphic anatomy, pathologic 
conditions, and sonographic 
indings. William Middleton, 
MD, professor of radiology 
at Mallinckrodt Institute, is 
one of the contributing 
authors. 
Published by Lippincott 
Williams & Wilkins of 
Philadelphia, the 768-page 
volume contains more than 
1,700 images as well as "key 
concept" tables to highlight 
essential information. The 
text has been hailed as "well 
organized, very readable, 
and a comprehensive text- 
book" by The Journal of 
Perinatology and was 
recommended by Chicago 
Medicine as a book that 





Mallinckrodt, a business 
unit of Tyco Healthcare, and 
Mallinckrodt Institute of 
Radiology (MIR) are part- 
ners in a five-year product 
agreement involving the 
manufacturing and 
distribution of F-18 fluo- 
rodeoxyglucose (FDG), a 
radiopharmaceutical used 
in positron emission tomog- 
raphy (PET) studies of the 
brain, cancer, and heart 
disease. 
As a leader in the pro- 
duction of contrast agents 
and radiopharmaceuticals, 
Mallinckrodt will provide 
expertise and assistance to 
the Institute in obtaining 
regulatory approvals and 
licensing of the MIR PET 
Center as a manufacturer 
and distributor of FDG. 
Initially, the MIR-produced 
FDG will be marketed to 
hospitals within a defined 
territory. 
This agreement is a 
continuation of a long-stand- 
ing relationship between 
Washington University, MIR, 
and Mallinckrodt. In 1923, 
Washington University 
researchers and Mallinck- 
rodt Company chemists 
developed a contrast media 
that, used with an X ray, 
produced the first visualiza- 
tion of a human gallbladder, 
a cholecystogram. Recogniz- 
ing that radiology would 
become an important med- 
ical specialty, Washington 
University administrators 
were determined that the 
University would establish 
one of the world's highest 
quality radiology depart- 
ments. Edward Mallinck- 
rodt, Sr. generously 
provided the funds for the 
building that would house 
the radiology department. 
On October 2,1930, the 
cornerstone was laid for 
the Edward Mallinckrodt 
Institute of Radiology at 
Washington University. 
PET, which was devel- 
oped in the 1970s by an MIR 
research team led by Michel 
Ter-Pogossian, PhD, uses 
positron emitting isotopes 
to assess chemical 
processes in the human 
body, producing images of 
function rather than of form. 
In PET studies, short-lived, 
cyclotron-produced radioac- 
tive nuclides of carbon, 
nitrogen, and oxygen are 
used to produce radio- 
labeled compounds nor- 
mally found in the body. 
These compounds, which 
are either inhaled by or 
injected into the patient, 
progress through the blood- 
stream and serve as indica- 
tors (or tracers) of normal 
physiological activity. While 
PET was initially used for 
basic research, the imaging 
device is increasingly being 





The September 2001 
issue of St. Louis Magazine 
included a listing of 148 of 
St. Louis' best physicians in 
53 specialties. The list was 
compiled by Castle Connolly 
Medical Ltd, a research and 
information company that 
profiles nearly 4,000 top 
referral specialists through- 
out the United States. Castle 
Connolly surveys area physi- 
cians, via mail and telephone 
surveys and electronic bal- 
lots, for their nominations. 
Emphasis is placed on 
patient care rather than 
academic excellence or 
research. The following 
doctors from the depart- 
ments of Radiology and 
Radiation Oncology were 
listed: 
■ DeWitte Cross, MD, associ- 
ate professor of radiology 
■ William McAlister, MD, 
professor of radiology 
■ Robert Myerson, MD, PhD, 
professor of radiation 
oncology 
■ Carlos Perez, MD, profes- 
sor of radiation oncology 
■ Stuart Sagel, MD, professor 
of radiology 
■ Barry Siegel, MD, professor 
of radiology 
■ Marie Taylor, MD, instruc- 
tor in radiation oncology. 








In the summer of 2000, 
David Piwnica-Worms, MD, 
PhD, professor of radiology 
and of molecular biology and 
pharmacology, received a $1.2 
million National Cancer Insti- 
tute (NCI) planning grant to 
establish a molecular imaging 
center at Washington Univer- 
sity. As principal investigator, 
Piwnica-Worms has now been 
awarded a five-year, $10.5 mil- 
lion NCI grant to move the 
Molecular Imaging Center 
(MIC) from the planning stage 
into a centralized resource 
for three molecular imaging 
cores, four multidisciplinary 
research projects, four devel- 
opmental research projects, 
an education program, and a 
training/career development 
program. 
By combining Washing- 
ton University Medical Center 
scientists' expertise in molec- 
ular oncology, immunology, 
molecular genetics, and signal 
transduction with Mallinck- 
rodt Institute's state-of-the-art 
imaging technology, the MIC 
collaborators hope to transfer 
the information obtained 
from molecular and genomic 
research into the develop- 
ment of novel imaging tech- 
niques beneficial to the 
diagnosis of cancer and the 
assessment of treatment 
effectiveness. More than 50 
investigators will study mole- 
cular targets in cancer cell 
biology, the validation of 
reporter constructs and 
reporter probes, the chem- 
istry of image-enhancing 
agents, drug pharmacokinet- 
ics, and a variety of imaging 
strategies. 
All areas of molecular 
imaging, including applica- 
tions of positron emission 
tomography (PET), single 
photon emission computed 
tomography (SPECT), mag- 
netic resonance (MR), optical, 
near infrared fluorescence, 
and bioluminescence, will 
be used in these studies. 
These MIC multidisciplinary 
projects are designed to 
better understand cellular 
changes relevant to cancer: 
■ in vivo imaging of gene 
expression in prostate 
cancer 
■ noninvasive monitoring of 
T cell-mediated tumor 
ablation 
■ imaging cancer viruses with 
Tat transducible peptides 
■ imaging MDR1 P-glycopro- 
tein transport activity in 
vivo with Tc-94m-sestamibi 
PET to predict response to 
chemotherapy in extensive 
stage small cell lung cancer. 
The MIC's major labora- 
tories will be housed on the 
ground floor of the Mallinck- 
rodt Institute of Radiology at 
Washington University Imag- 
ing Center, adjacent to the 
Institute's East Building at 
4525 Scott. Space on the 
Imaging Center's third floor 
will serve as offices for the 
MIC researchers and staff, 
and cell and molecular biolo- 
gists, molecular imaging 
scientists, chemists, and 
physician-scientists can 
communicate daily through 
the Virtual Center. 
Research Project Principal Carolyn Anderson, PhD, Resource Directors/Senior Scientific 
Investigators associate professor of radiology Advisors 
Paul Allen, PhD, Jacob Locke, MD, Joseph Ackerman, PhD, 
professor of pathology and of immunology instructor in radiation oncology professor of chemistry and of radiology 
Jeffrey Milbrandt, MD, PhD, Gary Luker, MD, Marcus Raichle, MD, 
professor of pathology and of immunology instructor in radiology professor of radiology and of neurology 
David Piwnica-Worms, MD, PhD, John Schotland, MD, PhD, and neurobiology 
professor of radiology and of molecular associate professor of electrical engineer- Barry Siegel, MD, 
biology and pharmacology ing and of radiology professor of radiology and of medicine 
Lee Ratner, MD, PhD, Michael Welch, PhD, 
professor of medicine and of molecular Core Managers professor of radiology and of chemistry 
mocrobiology Richard Laforest, PhD, 
assistant professor of radiology 
Development Project Principal Kathryn Luker, PhD, 
Investigators research instructor in radiology 
Samuel Achilefu, PhD, Vijay Sharma, PhD, 




Since 1985, the Editorial] 
Board of Radiology, a lead- 
ing scientific journal pub- 
lished by the Radiological 
Society of North America, 
annually has honored its 
most prolific manuscript 
reviewers. Of approximately 
800 reviewers this year, only I 
109 were selected to receive | 
the 2001 Radiology Editor's 
Recognition Award for 
reviewing with "Distinction." 
The following MIR physi- 
cians were among those 
honored. 
■ Kyongtae Bae, MD, PhD, 
assistant professor of 
radiology 
■ Louis Gilula, MD, professor 
of radiology and of surgery 
■ Christopher Moran, MD, 
associate professor of 
radiology 
■ Franz Wippold, MD, 
associate professor of 
radiology. 
MALLINCKRODT INSTITUTE OFRADIOD 
Radiation oncology is 
one of the first occupants 
of a multidisciplinary facility 
The Center for Advanced Medicine (CAM) — 
the magnificent, 14-story, glass-fronted build- 
ing at the corner of Forest Park Boulevard and 
Euclid Avenue — will be home to the clinical 
practices of more than 750 Washington Univer- 
sity physicians and is the first of the Washington 
University Medical Center's five-year campus 
integration projects to open. The Alvin J. 
Siteman Cancer Center at Washington Univer- 
sity School of Medicine (WUSM) and Barnes- 
Jewish Hospital will be the largest of the CAM 
building's multidisciplinary clinical centers, 
occupying the lower level and seventh floor 
for a total of more than 107,00 square feet. 
Wimtwi^ 




in one convenient 
location 
^B 
In August 2001, the Sit 
me the only cancer facility in 
mal recognition as a National Cancer Institute- 
signated Cancer Center. As part of the NCI 
gnition, WUSM received a $4 million federal 
t Mf 
it for basic an^Wmical cancer research and 
cancer prevention programs. 
PH 
Clinical facilities for the departments' 
and Radiation Oncology at 
will be among those housed in the CAM building. 
Currently, the Division of Diagnostic Radiology's 
musculoskeletal service has moved into level 6 
and the Clinical and Physics divisions of the 
Department of Radiation Oncology are in place in 
Ji lower level. Photos of radiation 
:ology's new home appear on the 
WBIM / fbllowih g pages. Watch for coverage of 
,••'// diagnostic radiology's new facilities 
\ Hwshing^pdzKsue of Focal Spot 
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Center for Advanced Medicine/Siteman Cancer Center 
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Jeff Michalski, MD, assistant professor 
of radiation oncology, completes a 
patient file in one of the new exam 
rooms. 
The expanded and centralized radiation 
oncology medical records. 
J 




James Purdy, PhD, professor of radiation oncology and director of the Physics Division, Department of Radiation 
Oncology, in his new office in the lower level of the CAM building. Physics was the first group to move into the 
new radiation oncology facility. 
S*B1•■■  -I 
First-floor lobby of 
the Center for 
Advanced Medicine. 
•»: 
Offices for hospital and medical school administrators include a roomy, 
open area for administrative assistants Karen Coleman, assistant to Todd 
Wasserman, MD, clinical chief; Bobbie Browning, assistant to Kathleen 
Brunsden, Barnes-Jewish Hospital director of radiation oncology; and Sonjia 
Stinger, assistant to Carlos Perez, MD, chairman of the Department of 
Radiation Oncology. 
Christine Schmitz, RN, 
(left) and Monica Miller, 
BJH radiation oncology 
staff, check patient 
records in one of the 
patient waiting areas. 
FOCAL SPOT, FALL/WINTER 2001 
This top-of-the-line Elekta linear 
accelerator is one of seven linear 
accelerators that will be installed in 
the radiation oncology facility. 
Genita Riley, clinical office assistant, has a smile on her face and in her 
voice when she talks to patients, visitors, and staff in the Radiation 
Oncology Center. 
»^   1 
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Under construction. Clinical 
will use computers in this area to 
monitor patients who are undergo- 
ing radiotherapy in one of the linear 
accelerator rooms. 
The Physician Workroom is large enough to accom- 
modate clinical staff. A workroom for radiation 
oncology nursing staff adjoins this area. 
The Resident Workroom contains 
computer space for the 12 radiation 
oncology residents and four physics 
residents. 
MALLINCKRODT INSTITUTE OFRADIOLOG) 
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SIFTING THROUGH THE CONFUSION OF 
Alzheimer's Disease 
by Barbra Rodriguez 
Alzheimer's Disea 
An investment banker asks 
someone else to prepare 
his tax return for the first 
time in decades. A retired 
nurse forgets to show up 
to volunteer at a hospital. A minis- 
ter who once proudly named 
congregation members now has 
trouble connecting a name with a 
face and cannot recall the food 
served at a wedding he presided 
over the day before. 
Things like this can happen 
when someone is mentally fatigued, 
has a harried schedule, or is dis- 
tracted. But when forgetfulness and 
confused thoughts become constant 
companions rather than occasional 
annoyances, it could signal an early 
stage of Alzheimer's disease. About 4 
million Americans have this progres- 
sive, degenerative brain disorder for 
which there is no known cure. 
For the past two years, a brain- 
imaging specialist at Mallinckrodt 
Institute of Radiology has been 
looking for telltale signs that may 
provide an early warning of 
Alzheimer's disease. If the magnetic 
resonance spectroscopy (MRS) 
work of Benjamin Lee, MD, associ- 
ate professor of radiology, pans out 
as a diagnostic tool, it could greatly 
impact patient care. 
About 4 million Americans have this progressive, 
degenerative brain disorder for which there is no 
known cure. 
IDENTIFYING PEOPLE AT RISK 
John Morris, MD, professor of 
neurology and director of the 
Healthy Aging and Senile Dementia 
(HASD) project at Washington Uni- 
versity School of Medicine, says 
such a diagnostic test is sorely 
needed. "It would be great to iden- 
tify people at risk for the disease 
before nerve cell damage occurs 
and then use disease-modirying 
interventions at that point," he says. 
Lee, who is studying 60 HASD vol- 
unteers using MRS, concurs. "We're 
hoping that imaging studies may 
provide the means whereby these 
cases can be picked up before 
clinical onset," he says. 
This study is part of one of the 
largest National Institutes of Health 
program projects on Alzheimer's 
disease, which have tracked a 
large number of volunteers for two 
decades. Many of the prospective 
studies from this program project 
indicate that the disease produces 
pathologic brain changes long 
before tests of mental status raise 
suspicions of its presence. In fact, 
the disease may begin to alter 
brain structures years — perhaps 
decades — before mental functions 
start faltering. 
Before this decline, dense 
deposits called neuritic plaques are 
thought to form outside neurons. 
Inside the nerve cells, twisted 
strands of fiber, or neurofibrillary 
tangles, also develop. These tangles 
disrupt the transport machinery that 
is essential in transferring signals 
between neurons, effectively cutting 
off the supply route needed to bring 
energy into the cells and remove 
toxic wastes. 
"When the brain cells begin to 
die, the memory and other thinking 
processes fail, and patients develop 
the symptoms of Alzheimer's dis- 
ease," says Lee. 
A class of drugs called 
cholinesterase inhibitors has already 
received United States Food and 
Drug Administration approval to 
treat the thought- and memory- 
robbing disease, and additional 
drugs are under development. The 
cholinesterase inhibitors do not cure 
but appear to prevent progression of 
Left: The gray matter of the brain is most affected 
in Alzheimer's disease. This chemical shift proton 
spectral technique evaluates the entire brain, including 
the cerebral cortex. 
Right: The hippocampus, a curved or scroll-like, 
complex portion of the temporal lobe of the brain, 
is often called the "memory center." 
I 
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Alzheimer's disease for up to several 
years. The later the drugs are given 
in the course of the disease, the less 
impact they have. 
MRS STUDY 
Lee is analyzing changes in key 
brain regions of 30 healthy volun- 
teers and of 30 volunteers believed to 
have mild dementia, attempting to 
capture the point, referred to as the 
flexion point, where the toxic effects 
of the plaques and tangles suddenly 
begin to cause nerve cell death. The 
volunteers are 65 years or older, 
which is when most cases of 
Alzheimer's disease begin to be 
diagnosed. 
If the MRS images successfully 
identify brain changes before some 
of the volunteers develop 
Alzheimer's symptoms, it would add 
to the list of diseases for which MRS 
has proven diagnostic value. Lee and 
others currently use the noninvasive 
imaging tool as a litmus test to help 
differentiate primary brain tumors 
from metastatic brain tumors, for 
example, and for distinguishing brain 
tumors from radiation-induced 
necrosis. 
Lee's study focuses on three 
brain regions that are damaged in 
Alzheimer's disease: the cerebral cor- 
tex, the hippocampus, and the cingu- 
late gyrus. These regions were 
selected for study because autopsies 
of volunteers who died while partici- 
pating in the HASD project showed 
that the neuritic plaques and neu- 
rofibrillary tangles of Alzherimer's 
disease appear in the regions first. 
The cerebral cortex forms the outer 
shell of the cerebrum, which pro- 
vides most of the brain's volume. The 
MRS imaging will be of the frontal 
The MRS assessments may do more than just catch 
an early snapshot of Alzheimer's disease in the brain; 
they may help redefine what aging is. 
and parietal lobes constituting the 
front and apical portions, respec- 
tively, of the cortex. 
The frontal lobe, which makes 
up half the brain volume by itself, 
transmits and processes information 
about multiple activities, including 
thought processes and memory. It 
organizes memories in sequence, 
controls a person's behavior, and is 
where problem solving occurs. The 
parietal lobe handles certain thought 
and certain sensations and is 
involved in reasoning and memory. 
The hippocampus, located below the 
cerebrum, plays an important role in 
memory processing. The cingulate 
gyrus, situated deep in the brain, 
also is essential for memory and is 
an additional focus of part of Lee's 
spectroscopic imaging. 
Lee will hunt for early signs of 
nerve cell damage in the hippocam- 
pus and cerebral cortex by detecting 
the spectroscopic signal of four bio- 
chemical markers. The first, n-acetyl 
aspartate, is found within neurons. 
The second, choline, occurs in the 
fatty, myelin sheaths that coat axons 
extending from nerve cells. A marker 
of general cellular metabolism, phos- 
phocreatine, also will be analyzed in 
both regions. In addition, Lee will 
evaluate the presence of a marker 
for the cingulate gyrus: myo-inositol. 
"That's a rather unusual metabolite, 
which is in some way connected 
with neuronal function," Lee says. 
The level of myo-inositol is 
markedly changed in the brain of 
people who have come close to 
drowning or have suffered from 
hepatic encephalopathy, a form of 
brain dysfunction brought on by 
liver damage. "There's preliminary 
evidence that the level of myo- 
inositol is increased in Alzheimer's 
disease," he says. 
With the assistance of Marcia 
Hendrix, research patient coordina- 
tor, Lee began performing MRS 
scans on the 60 HASD volunteers 
two years ago. All but about 10 have 
had an initial scan done so far, dur- 
ing sessions that last just over an 
hour per volunteer. 
Follow-up scans on some of the 
same volunteers began recently. 
When more of these scans have been 
done, Lee will begin comparing the 
spectroscopic graphs from the first 
and second rounds of imaging. 
If, as suspected, some of the 
neurons in volunteers with mild 
dementia have begun dying by the 
second round of imaging, this will 
show up as smaller peaks of the bio- 
chemical markers on the second 
spectroscopic graphs. "If we can 
detect the difference in this group, 
then we will gain some handle on 
what's happening in the brain during 
Alzheimer's disease," Lee says. 
FOCAL SPOT, FALL/WINTER 2001 
ALZHEIMER'S DISEASE (AD) FACTS 
AND FIGURES 
■ AD is the most common 
cause of dementia among 
people 65 and older. 
■ Scientists estimate that approxi- 
mately 4 million people in the 
United States have AD. 
■ The prevalence of AD doubles 
every 5 years beyond age 65. 
■ An estimated 360,000 new cases 
of AD will occur each year. 
■ One study shows that nearly 
half of all people 85 and older 
have some form of dementia. 
■ African Americans and Hispanic 
Americans may have a higher 
overall risk of AD than do 
Caucasians. 
■ One study estimated that the 
annual cost of caring for one 
patient with mild AD is $18,408; 
$30,096 for a patient with mod- 
erate AD; and $36,132 for a 
patient with severe AD. 
Excerpted from The Impact of 
Alzheimer's Disease. Available at 
www.alzheimers.org, the web site of 
Alzheimer's Disease Education and 
Referral Center, a service of the 
National Institute on Aging, 
National Institutes of Health, U.S. 
Department of Health and Human 
Services. 
He is particularly excited to 
review data of the cerebral cortex, 
which no one has previously ana- 
lyzed with spectroscopy. The outer 
surface of the cerebrum had been 
difficult to image because neuronal 
signals become contaminated by 
those of fat cells located on the sur- 
face of the skull and within the skull 
bones. Lee and his colleagues at 
Mallinckrodt Institute developed a 
two-dimensional, multi-voxel imag- 
ing technique known as outer-vol- 
ume suppression to overcome this 
difficulty. "It suppresses the fat sig- 
nal on the skull, so we can accumu- 
late data right out to the surface of 
the brain, and therefore look at the 
cortex," Lee says. 
The MRS work also will be com- 
pared to high-resolution magnetic 
resonance imaging (MET) that Lee is 
doing of the same volunteers. In par- 
ticular, he is studying whether a part 
of the hippocampus decreases in size 
among imaging study volunteers. 
This part, known as CA1, extends the 
entire length of the hippocampus. 
The CA1 is a relay station for the pro- 
cessing of memories and develops 
the most neuritic plaques and neu- 
rofibrillary tangles in the hippocam- 
pus. "We have developed a method 
to separate out that portion of the 
hippocampus from the rest of the 
hippocampus," Lee says, referring to 
an analysis program developed by a 
Mallinckrodt Institute research 
group in the 1990s. 
MAPPING THE HIPPOCAMPUS 
Lee's MRI work will complement 
that of John Csernansky, MD, profes- 
sor of psychiatry. Csernansky, who is 
studying the entire hippocampus of 
the same volunteers Lee is using in 
his MRS study, is creating three- 
dimensional reconstructions of MRI 
images to detect changes in the shape 
of specific hippocampal regions. 
These shape changes likely signal a 
loss of volume resulting from the 
neuronal loss in Alzheimer's disease. 
The subjects studied by Lee, 
Csernansky, and other imaging spe- 
cialists were carefully classified as 
"healthy" or "early dementia" by the 
HASD medical staff. The staff used 
an involved series of medical and 
mental function tests developed by 
investigators in the program project 
to make these decisions. A battery of 
mental function, or psychometric, 
tests had to be used because the 
early Alzheimer's symptoms are 
often too subtle to be detected with 
standard clinical methods. Their 
assessments, which allow accurate 
identification of the disease 93 per- 
cent of the time, will be compared to 
the imaging results of the volunteers 
once the blinded imaging studies are 
completed. 
The MRS assessments may do 
more than just catch an early snap- 
shot of Alzheimer's disease in the 
brain; they may help redefine what 
aging is. In the early 1990s, under the 
leadership of former HASD director 
Leonard Berg, MD, professor emeri- 
tus of neurology, Morris and others 
provided evidence that the disease is 
a distinct process from normal aging. 
In support of this theory, some of the 
HASD volunteers have been found to 
maintain the same, healthy mental 
status for as long as 15 years. EH 
L. 
12 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
Radiology in the Cradle 
Considered by many anthropologists as the "cradle of humanity," the old- 
est human remains found in Kenya date to the Early Stone Age. Over the 
following centuries, this wild and beautiful land of pristine beaches, mag- 
nificent mountains, exquisite flora, and diverse fauna became home to 70 
African tribal groups as well as thousands of Europeans. Kenya was 
under British colonial rule from the late 1800s until independence was 
won in 1963. In 1964, Kenya became the Republic of Kenya. Jomo Keny- 
atta, Kenya's founding father, was named the country's first president. 
On September 1, 2001, five neurosurgeons, two anesthesiologists, 
four nurses, a physical therapist, and a neuroradiologist comprised 
a collaborative team from St. Louis that traveled to Kenyatta National Hospi- 
tal (KNH) in Nairobi, Kenya, to provide free medical care to KNH patients. 
This was the second, of what is to be an annual, trip of the Saint Louis (STL) 
Neurosurgical Mission, a volunteer group started by two local neurosurgeons, 
Paul Young, MD, and Ken Smith, MD. The STL team worked side-by-side 
with medical staff in Kenya to provide educational lectures and clinical eval- 
uations, train medical personnel, and perform surgeries on selected patients. 
BY THOMAS PETERS 
Cradle of Humanity 
► 
FACTS AND FIGURES 
n Capital city: Nairobi 
~i Population: 30 million* 
Area: 224,961 square miles 
Official Languages: English and Swahili 
Ethnic languages: Bantu (Luhya, Kikuyu, 
Kamba, Mijikenda); Cushitic (Oromo, 
Somali); Nilotic (luo, Kalenjin, Masai) 
■ Government: Multiparty, 
since 1991 
Michael Chicoine, MD, and Carl Lau- 
ryssen, MB ChB, Washington Univer- 
sity neurosurgeons, were returning 
team members, and accompanying 
the group for the first time was 
David Jeck, MD, a Mallinckrodt Insti- 
tute of Radiology (MIR) clinical fel- 
low in interventional neuroradiology. 
The following is a recounting of 
Jeck's medical and personal experi- 
ences in Kenya. 
Right: Dr. Jeck and University of Nairobi radiology 
residents during a teaching session. 
Far Right: (right to left) Dr. Moody Qureshi, 
Kenyatta Hospital surgeon; Dr. Dennis Rivet, 
Washington University neurosurgeon; Janet 
Jones, RN; and Kenyan surgical registrars. 
Adjusting to Kenya's 
healthcare system 
The airplane flight from 
St. Louis to Kenya took 24 hours, 
but once the STL Neurosurgical 
Mission team arrived in Nairobi 
they were anxious to begin their 
two weeks of humanitarian work. 
Initially, the team was given a half- 
day tour of KNH (a public hospital) 
and of Aga Khan Hospital (a local 
private hospital). The disparity of 
medical facilities and patient care 
was immediately evident to the 
team. Kenyatta National Hospital 
serves as the only public hospital 
for a city of more than 2 million 
people, not including large num- 
bers of patients from outside the 
city. Considered the best public 
hospital in sub-Saharan Africa, 
KNH also receives referrals from 
the entire region. 
"The number of people who 
come to KNH far exceed the hospi- 
tal's treatment capabilites," says Jeck. 
"Once the patients arrive at KNH they 
often are left unattended in hospital 
beds for long periods of time, waiting 
for surgery when they should have 
received emergency care." 
Added to the overwhelming 
number of patients is the hospital's 
lack of funding. Patients often must 
purchase their own medical sup- 
plies, such as ventricular shunts or 
aneurysm clips, on the black mar- 
ket. The patient sometimes buys 
inappropriate equipment, and the 
doctors must try to "make do." 
Fortunately, the STL team brought 
a large number of donated equip- 
ment with them, allowing the team 
to perform surgery without most 
of the impediments faced by the 
KNH physicians and providing the 
hospital with supplies to last the 
balance of the year. 
During the second half of the 
day the STL team met patients, 
reviewed cases, and determined 
which patients were good candi- 
dates for surgery. Some of the 
patients had been seen during the 
first STL Neurosurgical Mission 
trip to Kenya in 2000; others were 
new referrals. As Jeck indicates, 
"The task of selection was over- 
14 MALLINCKRODT INSTITUTE OF RADIOLOGY 
vhelming when you, as a physi- 
:ian, see more than one hundred 
latients sitting in a room, holding 
their own medical records and CT 
and MRI scans - all of them hoping 
they will meet the criteria for 
surgery. Selection is based on 
the more difficult cases and 
on those patients who have the 
best chance of recovery." 
For the balance of the first 
week, the STL team performed 
surgery on the patients seen on the 
first clinic day. During the second 
week the team saw a new group 
of patients, reviewed new cases, 
and selected patients who met 
surgical criteria. "Some of the 
patients who were not selected 
for treatment this year are good 
candidates for treatment on the 
next trip," says Jeck. 
Specific cases at KNH 
Jeck found that the clinic 
patients could be divided into two 
categories: those with diseases 
similar to or commonly found in 
the United States but with more 
advanced symptoms, and those 
with diseases that are less preva- 
lent in the United States. In the 
first group were patients with 
advanced, benign meningiomas, 
extreme hydrocephalus, and 
spina bifida. 
"Kenyan patients tend to be 
more stoic about their medical 
problems than are patients in the 
United States," says Jeck. "Kenya 
has poorly funded medical care, 
and there are inadequate health 
insurance systems in place. Kenyan 
patients delay seeing a doctor until 
the disease has advanced because 
the cost of medical care that must be 
paid for out of the patient's pocket is 
more than most patients can afford." 
The problem with this wait- 
and-see approach is that advanced, 
potentially curable diseases can 
lead to life-threatening debilitations 
and/or death. Several patients 
DOWNTIME 
Between clinics and lectures, the neu- 
rosurgery team traveled to Ngoron- 
goro Crater in northern Tanzania. The 
trip began with a (light from Nairobi, 
Kenya, to Tanzania's Kilimanjaro 
International Airport. From the air- 
port to the crater required a six-hour 
van ride over extremely bumpy 
roads. Over the next two days the 
group was collectively driven down 
into the crater where a tremendous 
number of animals, including lions, 
zebras, and hippopotamuses, would 
venture close to the vans. And they 
also were able to catch a glimpse of 
the local Masai tribe's way of life. 
This safari allowed Jeck and his 
teammates to experience African 
wildlife up close and provided a brief 
respite before another week of long 
clinic days and lectures. 
VALLEY 
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seen during the trip had untreated 
advanced meningiomas (brain 
tumors) that led to incredibly large 
tumor masses,causing blindness and 
other irreversible brain damage. 
Alternatively, spina bifida (a congeni- 
tal cleft of the spine, causing a hernia 
in the membrane covering the spine) 
is more prevalent in malnourished 
Third World countries such as 
Kenya. Infections develop if spina 
bifida is not treated early. Advanced 
untreated hydrocephalus (enlarged 
ventricles in the brain) in children is 
also relatively commoin. 
A large percentage of KNH 
inhouse patients tested positive for 
the human immunodeficiency virus 
(HIV), which leads to acquired 
immune deficiency syndrome 
(AIDS). And the team saw patients 
with diseases rarely found in the 
United States such as different 
types of brain infections, including 
intracranial tuberculoma and 
hydatid. 
According to Jeck, some of the 
landmark cases on this trip included 
a child with failed muscular coordi- 
nation (ataxia) who had a posterior 
fossa tuberculoma; an infant with an 
extremely large brain hernia (occipi- 
tal encephalocele); a man with 
enlarged bones and extremities 
(acromegaly) - he was over seven 
feet tall - who had a pituitary tumor; 
and a boy with a large neck mass and 
a large nerve cell tumor (jugular 
schwannoma) that caused the 
deterioration of part of his tongue. 
Crash course in neuroradiology 
"There are few neuroradiolo- 
gists and no neurointerventional 
radiologists in Kenya," says Jeck. 
So, in addition to clinical work, Jeck 
presented a series of lectures and 
grand rounds and conducted training 
workshops for a broad audience of 
Kenyan physicians: "Endovascular 
treatment of aneurysms" to the 
Kenyan Radiological Society; "An 
overview of neuroradiology" at the 
Aga Khan Neuroscience Symposium; 
grand rounds at Kenyatta National 
Hospital; "Cerebral vascular malfor- 
mations" to Kenyatta Hospital radiol- 
ogists. And he led multiple teaching 
sessions with small groups of Univer- 
sity of Nairobi radiology residents, 
who were eager to learn and quickly 
comprehended new information and 
techniques. 
Reflections 
"The Saint Louis Neurosurgical 
Mission was limited in time and man- 
power to make any more than a dent 
in the multitude of cases at KNH," 
says Jeck. But he says that his volun- 
teer mission in Kenya was extremely 
rewarding, "I gained.at least as much 
as I could provide. I saw an incredi- 
ble variety of pathology in patients 
that is only seen in textbooks in the 
United States." 
Jeck found that the exemplai 
support and training he received 
at MR was a tremendous asset 
and also put into perspective the 
situation dealt with in American 
healthcare. "In Kenya, physicians 
have to practice medicine with 
what is available despite not having 
enough materials or resources," 
he says. 
Jeck plans to travel with the 
2002 Kenyan STL Neurosurgical M 
sion, adding that "there were a nun, 
ber of patients identified with 
aneurysms and other vascular mal- 
formations who were not treated 
on the 2001 trip; they would be 
potential candidates for endovascu- 
lar treatment next year." And he 
hopes that next year a group of MIR 
radiologists and support staff can 
join him on this enriching multi- 
institutional humanitarian effort 
to help the people of Kenya 
Moody Qureshi, MD (right) and H.W. Waweru, dire 
tor, Kenyatta National Hospital. 
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wahili: "Let's all 
ill together.) 
On September 11, five days 
efore the team was scheduled 
'■> return to the United States, 
terrorist attacks occurred in 
Washington DC, New York City, 
id Pennsylvania. For Kenyans 
nd the American team in Kenya, 
jptember 11 was a vivid and 
linful reminder of the terrorist 
jmbing of two United States 
mbassies in East Africa on 
August 7, 1998, resulting in 213 
'including 12 Americans) deaths 
in Nairobi, Kenya, and 11 deaths 
in nearby Dar es Salaam, Tanza- 
nia. According to CNN news 
reports, more than 4,500 people 
were injured in these two attacks. 
lelow: Kenyan mother with her young son who has 
ydrocephalus. 
low Right: CT images of a patient with tuberculoma. 
ilow Far Right: Dawn Schuessler, RN, and her 
iend in a corridor at KNH. 
David Jeck remembers that 
when he heard the news he was at 
a lecture for Kenyan doctors and 
his immediate reaction was "to 
be with other Americans." Jeck 
says the Kenyans were extremely 
supportive, sympathetic, and 
pro-American.   In fact, Jeck 
recalls that teenage boys came 
up to him on the street to say that 
America was in their prayers. 
The ensuing lockdown of 
American airports led to several 
team members staying an addi- 
tional four days in Kenya. Dur- 
ing that time the team continued 
their daily routines, monitored 
the developments on CNN and 
BBC America, and felt fortunate 
they were not stranded in an 
airport.  "Members of the STL 
Neurosurgical Mission bended 
because there were not many 
Americans in Kenya," says Jeck. 
He says that keeping busy, inter- 
acting with the neurosurgery 
team, and being surrounded by 
hospitable Africans helped ease 
the stress until his return to the 
United States. EH 
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Two PET images (top) 
showing the distribution of 
[F18]altonserlnin the 
brain of a study volunteer 
who has depression. The 
binding of [F18]altanserin 
in the brain shows the 
location and number of 
serotonin-2A receptors. 
The MRI images on the 
bottom are coregistered to 
the PET images to allow 
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n the frustrating world of clinical depression, there are a few generally 
agreed-upon facts. We recognize the symptoms of the disease: the sleepless- 
ness, the inability to concentrate, the lack of joy in life. We understand its 
devastating impact on people's lives, from the nearly 19 million people who 
suffer from it to the more than 30,000 suicides in the United States each year, 
many of them depression-related. Thanks to the success of some anti-depres- 
sant drugs in ameliorating the effects of depression, particularly the class of 
drugs known as selective serotonin reuptake inhibitors (SSRIs), we also feel 
confident that depression is biologically based. 
But all the rest — the roots of the disease, the best treatments — is still 
shrouded in mystery. "We have theories, but no firm idea at all, about what 
precipitates depression. There is an incredibly small amount of data on what 
is biologically different in the brains of people who are depressed," says Mark 
Mintun, MD, professor of radiology and of psychiatry. 
Beginning at the University of Pittsburgh seven years ago, and then at 
Mallinckrodt Institute of Radiology (MIR) for the past four and a half years, 
Mintun has carried out a series of research projects aimed at unraveling this 
mystery with the help of positron-emission tomography (PET).  The question 
he has asked is a basic one: Is there a biological change in the brain that may 
point to the cause of depression? If so, is it just one piece in a whole cascade 
of changes that medicine needs to understand? In depression, most of the 
brain still works well, so any imbalance is likely quite subtle. 
Mintun's findings offer new evidence that anomalies in the brain's sero- 
tonin system play an important role in setting the stage for depression. And his 
most recent research takes that understanding one step further: demonstrating 
that the brain's hippocampus shows a striking serotonin abnormality in people 
with depression. While more work remains to be done, these discoveries may 
have important implications for treating not only depression but also 
a host of other diseases, including Parkinson disease and epilepsy. 
by Candace O'Connor 
TRACING THE 
depression 
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Research background 
In thel980s, Mintun completed a 
residency in nuclear medicine at 
MIR and then, as a young faculty 
member, worked with Marcus 
Raichle, MD, professor of radiology 
and of neurology and neurobiology, 
and Steven Petersen, PhD, professor 
of neurology (neuropsychology) and 
of radiology, on mapping complex 
language pictures in the brain using 
PET. But a decade ago, he decided 
on a new focus for his research. 
"I felt that the biggest impact of 
new advances in brain imaging 
would be in mental health," he says. 
" This was an area that had been 
held back for a long time because we 
couldn't get good information about 
what was going on. So I directed my 
efforts at developing new techniques 
toward that goal." 
He chose to focus on the brain's 
serotonin system, which clearly 
plays some role in depression. After 
all, the SSRIs, which alter the 
amount of serotonin in the brain, 
have had an enormous effect on the 
treatment of the disease. But scien- 
tists are still divided as to whether 
serotonin is itself the cause or part 
of a cascade effect.  In treating 
depression, some drugs that don't 
affect serotonin directly, as well 
as treatments such as electro- 
convulsive therapy (ECT), have also 
proven helpful. 
At Pittsburgh, Mintun began by 
studying the result of giving normal 
and depressed people a drug that 
rapidly stimulates the serotonin sys- 
tem. Next he measured the effect of 
this drug, using the subjects' glucose 
metabolism as a benchmark. While 
the brains of the healthy patients had 
changed, the brains of depressed 
patients showed a very muted 
response; their serotonin systems 
seemed to be malfunctioning. This 
finding supported the study hypothe- 
sis that depression is associated with 
reduced serotonin activity. 
So Mintun decided to target the 
small number of serotonin receptors 
scattered throughout the brain. The 
receptors are critical elements in cel- 
lular communication, "listening" to 
neurotransmitter signals sent by the 
brain's synapses. Among these sero- 
tonin receptors, the 
most common is the 




tors in their brain? he 
wondered. Perhaps 
that would account 
for their impaired 
serotonin function. 
"I also wanted to ask a second 
question: If the number of 5-HT2A 
receptors is altered, does treatment 
with anti-depressants fix the prob- 
lem? People with depression do get 
better; maybe their receptor change 
goes back to being normal," he says. 
New findings 
In his next study, Mintun wanted to 
develop a way of imaging these 
5-HT2A receptors to see whether 
they were, in fact, abnormal. In 
work that began at Pittsburgh and 
continued at Mallinckrodt Institute, 
he planned to inject subjects with a 
compound, tagged with a small 
amount of radioactivity, that would 
circulate throughout the body, move 
into the brain, and bind to the 5- 
HT2A receptors. Using PET imaging, 
Dr. Mark Mintun was recently appointed to the NIH's Integrative, Functional 
and Cognitive Neuroscience Study Section of the Center for Scientific Review. 
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"I FELT THAT THE BIGGEST IMPACT OF 
NEW ADVANCES IN BRAIN IMAGING 
WOULD BE IN MENTAL HEALTH. 
THIS WAS AN AREA THAT HAD BEEN 
HELD BACK FOR A LONG TIME BECAUSE 
WE COULDN'T GET GOOD INFORMA- 
TION ABOUT WHAT WAS GOING ON. 
SO I DIRECTED MY EFFORTS AT 
DEVELOPING NEW TECHNIQUES 
TOWARD THAT GOAL." 
he would then visualize these recep- 
tors and assess changes in them that 
might provide insight into the nature 
of the dysfunction in these serotonin 
pathways. 
Synthesizing the compound they 
needed to do this research -18F 
altanserin - was difficult. Thisligand 
had to be able to bind tightly enough 
to the 5-HT2A receptors so they 
could be seen during the imaging 
process, yet not bind to other recep- 
tors and confuse the picture. Mintun 
credits Stephen Moerlein, PhD, asso- 
ciate professor of radiology, and 
Mallinckrodt Institute's entire 
radiochemistry group, under the 
leadership of Michael Welch, PhD, 
professor of radiology and of chem- 
istry, with providing the extraordi- 
nary assistance that made this 
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diagnostic radiology resident, and 
Andrei Vlassenko, MD, PhD, 
research associate, contributed 
their expertise in the processing of 
the data. 
Three years ago, this ligand 
development work was complete 
and the study was ready to begin. 
Mintun and Yvette Sheline, MD, 
assistant professor of psychiatry and 
of radiology, along with Abraham 
Snyder, MD, radiology research sci- 
entist, recruited a group of healthy 
control subjects and 39 patients diag- 
nosed with depression (men and 
women, ages 20 to 70) and used 18F 
altanserin and PET to evaluate their 
5-HT2A receptors. The results were 
barely significant for most of the 
brain; there was only a modest 
decrease in the number of 5-HT2A 
receptors.  But when the 
researchers looked at the region of 
the brain called the hippocampus (an 
area known to control aspects of 
memory, mood, and behavior), the 
results were much more striking. 
"The hippocampus had a much 
larger decrease, approximately thirty 
percent," says Mintun. "That leads to 
a possible hypothesis: Perhaps this 
vital area of the brain is not able to 
function properly in depression 
because there are not the proper 
number of 5-HT2A receptors. So it 
Serotonin receptor binding in controls and subjects 
with depression at baseline over the lifespan: 
hippocampus region. 
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may be that a person with depres- 
sion does not recover as much from 
stress or bounce back as fast. We 
just don't have those answers yet." 
This experiment led to another 
startling finding, which will soon be 
published in the American Journal 
of Psychiatry. While collecting 
the data on these subjects, the 
researchers noticed that the older 
people had lost an overwhelming 
number of these 5-HT2A receptors. 
In fact, more than half were gone by 
the time people reached age 50. 
"Is that the unfortunate conse- 
quence of stress? This loss seems to 
occur at different rates in different 
people," Mintun says. "Or is this a 
planned loss? After all, we are not all 
depressed at age fifty. On the other 
hand, what if these receptors help us 
recover from stress and losing them 
makes it harder to bounce back? We 
don't yet have the answers." 
Future work 
for Mintun and his colleagues, 
much more research is still to be 
done. They feel confident that, 
within the hippocampus, there is 
a depression-related abnormality in 
the serotonin system. But the hip- 
pocampus is tightly interconnected 
with other areas of the brain. Per- 
haps a serotonin abnormality here 
has a broader effect — for example, 
on the regulation of dopamine in the 
brain. Scientists already know that 
dopamine is involved in helping peo- 
ple feel well, and there is evidence 
that people with Parkinson disease, 
which is related to dopamine prob- 
lems, have an unusually high rate of 
depression. 
In the future, Sheline will also 
pursue another, closely associated 
question: How do the hippocampus 
and related structures respond to 
things that generate an emotional 
response, such as a picture of a 
face that is unhappy or afraid? 
She will give subjects this kind of 
picture to look at, then map their 
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looking at the 
biological anom- 
alies that exist 
when people are 
depressed. Are 
these anomalies, 
such as a 
reduced number 
of serotonin 
"THESE ARE VERY COMPLICATED 
THINGS, AND IN MANY OF THESE 
AREAS WE DON'T HAVE A HANDLE ON 
WHAT THE NORMAL FUNCTION IS, 
MUCH LESS HOW THEY ARE ALTERED IN 
DEPRESSION." 
MALLINCKRODTINSTITUTE OFRADIOLOGl TOC 
"THERE IS NO MAGIC BULLET HERE. WE 
ARE NOT GOING TO FIND THE ONE 
ABNORMALITY WITH DEPRESSION, FIX 
THAT ONE THING, AND EVERYBODY IS 
GOING TO BE HAPPY. THIS IS A VERY 
COMPLICATED PROBLEM, BUT WE ARE 
NOW BEGINNING TO UNDERSTAND IT." 
receptors, present from birth, mean- 
ing that some people are genetically 
susceptible to depression? Or are 
they caused by something that regu- 
lates the serotonin system? He may 
also look at the effects of these 
anomalies on the symptoms gener- 
ated by the disease. "These are very 
complicated things, and in many of 
these areas we don't have a handle 
on what the normal function is, 
much less how they are altered in 
depression," says Mintun. 
Images of the statisti- 
cal T-test and MR I 
showing regions of 
significant decrease in 
[18F]altanserin bind- 
ing between the sub- 
jects with depression 
and the control groups. 
In patients with 
depression, there is 
decreased 
[18F]altanserin bind- 
ing in the parahip- 
pocampal regions 
bilaterally (p<0.01) 
and in the insular cor- 
tices bilaterally 
(P<0.01). 
Finally, he says, he would like to 
know more about where this under- 
standing of causes and effects leads 
in terms of designing new treat- 
ments for depression. Scientists 
know that neurogenesis occurs 
within the hippocampus; it can grow 
new neurons as part of normal learn- 
ing and adaptation. Existing brain 
cells can also grow whole new parts 
and connections. 
But what if this ability is some- 
how blocked, and this inability 
shows up as decreased 5-HT2A 
receptors? Sheline, Mintun, and 
Welch have recently been awarded a 
grant by Fidelity to develop ways to 
image these neurons as they are born 
in the human brain. Eventually, they 
hope to be able to determine 
whether people deficient in 5-HT2A 
receptors are also failing to grow 
new neurons at a normal rate — 
whether they have hippocampuses 
that are unable to "reinvent" them- 
selves, adapting to the environment. 
If that is true, perhaps it is also possi- 
ble to develop a drug to act upon the 
chemicals that signal cells within the 
neurons to grow. 
So far, Mintun says, one thing 
has become clear. "There is no 
magic bullet here," he says. "We are 
not going to find the one abnormality 
with depression, fix that one thing, 
and everybody is going to be happy. 
This is a very complicated problem, 
but we are now beginning to under- 
stand it." DEI 
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In this section, the names of employees who are full-time 
faculty or staff or who have an appointment in the 
Department of Radiology or Department of Radiation 
Oncology are highlighted in boldface type. 
GRANTS 
PROMOTIONS 
Colin Derdeyn, MD, assis- 
tant professor of radiology, 
was promoted to associate 
professor of radiology, Divi- 
sion of Diagnostic Radiology. 
Debra Gusnard, MD, 
instructor in radiology, was 
promoted to assistant pro- 
fessor of radiology, Division 
of Radiological Sciences. 
Richard Laforest, PhD, 
instructor in radiology, was 
promoted to assistant pro- 
fessor of radiology, Division 
of Radiological Sciences. 
Vadim Markel, PhD, assis- 
tant professor of radiology, 
Division of Radiological 
Sciences. 
Yuan-Chuan Tai, PhD, 
assistant professor of radiol- 
ogy, Division of Radiological 
Sciences. 
Zheng Wang, PhD, research 
instructor in radiology, 
Division of Radiological 
Sciences. 
Imran Zoberi, MD, instruc- 
tor in radiation oncology, 
Department of Radiation 
Oncology. 
Samuel Achilefu, PhD, 
associate professor of radiol- 
ogy, as principal investiga- 
tor, received a National 
Science Foundation Award 
in the amount of $620,000 to 
study "Novel RGD peptide 
dendrimeric optical contrast 
agents for imaging tumor 
angiogenesis." Coinvestiga- 
tors for the three-year award 
are John Schotland, MD, 
PhD, associate professor of 
electrical engineering and of 
radiology, and Carolyn 
Anderson, PhD, associate 
professor of radiology and 
of molecular biology and 
pharmacology. 
Carolyn Anderson, PhD, 
associate professor of radiol- 
ogy and of molecular biology 
and pharmacology, as princi- 
pal investigator, received a 
one-year grant from the 
United States Department of 
Defense to study "Radiola- 
beled matrix metallopro- 
teinase inhibitors for breast 
cancer therapy." As princi- 
pal investigator, Anderson 
also received a $236,970 
grant from the United States 
Department of Energy to 
fund "Graduate research in 
nuclear medicine at Wash- 
ington University." 
NEW FACULTY 
Lisa Connor, PhD, 
research instructor in 
radiology, Division of 
Radiological Sciences. 
Jose Garcia-Ramirez, MS, 
instructor in radiation 
oncology, Department of 
Radiation Oncology. 
Kathryn Luker, PhD, 
research instructor in 
radiology, Division of 
Radiological Sciences. 
Melson Lecture 
On September 10, Alec Megibow, MD, professor of radiology and vice chairman for edu- 
cation, Department of Radiology, New York University Medical Center, presented the 
Ninth Annual G. Leland Melson Visiting Professorship and Lecture, "CT/MR of pancre- 
atic neoplasms." Shown with Megibow (second from left) are doctors Jay Heiken, chief 
of abdominal radiology; William Middleton, professor of radiology; and Sharlene Teefey, 
head of ultrasonography. 
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Steven Don, MD, assistant 
professor of radiology, as 
principal investigator, 
received a $100,000 National 
Institutes of Health (NIH) 
grant for "Neonatal chest 
phantom for computed radi- 
ography testing." The one- 
year grant was awarded in 
conjunction with NIH's 
Small Business Technology 
Transfer Program with 
Gamma RMI, a Wisconsin- 
Dased corporation that is an 
mnovator of quality control 
devices for radiology. Coin- 
vestigators are Bruce Whit- 
ing, PhD, and Charles 
Hildebolt, DDS, PhD. 
William Powers, MD, pro- 
fessor of neurology and of 
radiology, as principal inves- 
tigator, received a $900,000 
grant from the National Insti- 
tutes of Health/National 
Institute of Neurological 
Disorders and Stroke 
(NINDS) for "Cerebral 
mitochondrial metabolism in 
neurodegeneration." Coin- 
vestigators for the four-year 
project are Joel Perlmut- 
ter, MD, professor of neu- 
rology and of radiology, and 
Tom Videen, PhD, research 
assistant professor of neurol- 
ogy and of radiology. As 
principal investigator, 
Powers also received a $14 
million-plus NINDS grant for 
a Carotid Occlusion Surgery 
Study. Robert Grubb, MD, 
professor of radiology and of 
neurology is co-principal 
investigator. Videen and 
Colin Derdeyn, MD, associ- 
ate professor of radiology, 
are coinvestigators. 
Joseph Roti Roti, PhD, 
professor of radiation oncol- 
ogy and director of Division 
of Radiation and Cancer 
Biology, and Eduardo 
Moros, PhD, associate pro- 
fessor of radiation oncology, 
were awarded a one-year 
research/testing agreement 
in the amount of $85,974 
with Integrated laboratory 
Systems, Inc. for the project 
"RTL development and con- 
trol for high SAR exposures." 
Jie Zheng, PhD, research 
assistant professor in radiol- 
ogy, received the Whitaker 
Foundation's Biomedical 
Engineering Research Pro- 
gram grant for $210,300. 
The two-year grant will sup- 
port his research on "In vivo 
assessment of myocardial 
oxygen extraction ratio with 
magnetic resonance BOLD 
effects." Coinvestigators are 
Dmitriy Yablonskiy, PhD, 
assistant professor of radiol- 
ogy; Robert Gropler, MD, 
associate professor of radiol- 
ogy; and Nikolaos Tsekos, 
PhD, assistant professor of 
radiology. Consultant is 
Debiao Li, PhD, Northwest- 
ern University. 
APPOINTMENTS/ELECTIONS 
Samuel Achilefu, PhD, 
associate professor of radiol- 
ogy, was appointed to the 
editorial board of the Jour- 
nal of Biomedical Optics, 
which is published by the 
International Society for 
Optical Engineering. 
Louis Gilula, MD, profes- 
sor of radiology and of 
surgery, was appointed orga- 
nizer of the International 
Wrist Investigators' Work- 
shop held on October 3 in 
Baltimore, Maryland 
Jacob Locke, MD, instruc- 
tor in radiation oncology, 
has been appointed to the 
Washington University 
Human Subjects Committee. 
Eduardo Moros, PhD, 
associate professor of radia- 
tion oncology, was 
appointed a member of the 
North American Hyperther- 
mia Society (NAHS) 2001- 
2002 Finance Committee, the 
Membership Committee, and 
the Web Site Committee, and 
as the American Association 
of Physicists in medicine liai- 
son for the NAHS. He was 
appointed a member of the 
Program Committee for the 
2002 meetings of the Radia- 
tion Research Society and 
the North American Hyper- 
thermia Society. Moros 
was appointed chair of the 
scientific session "Visualiza- 
tion and imaging in biotrans- 
port" at the International 
Mechanical Engineering 
Conference and Exhibition, 
New York City, New York, 
November 16. 
Mark Oswood, MD, PhD, 
clinical fellow in neuroradi- 
ology, was appointed to a 
three-year term on the Amer- 
ican College of Radiology 
Committee on Residency 
Training in Diagnostic 
Radiology. 
Joseph Roti Roti, PhD, 
professor of radiation oncol- 
ogy and director of Division 
of Radiation and Cancer 
Biology, was elected to a 
three-year term as president 
of the 9th International 
Congress of Hyperthermic 
Oncology and to a three-year 
term as councilor of the 
Bioelectromagnetics 
Society. He was appointed 
to the Awards and Honors 
Committee and the Program 




Fengming Kong, MD, PhD, 
assistant in radiation oncol- 
ogy, received the American 
Association for Women Radi- 
ologists' Research and Edu- 
cation Foundation 
Member-in-Training Award 
in Radiation Oncology. The 
award was presented for 
Kong's paper on "3D analysis 
of lung & heart dose to 
decipher central lung/heart 
distances and radiation tech- 
niques for intact breast irra- 
diation: adding a medial 
breast port decreases vol- 
ume of lung and heart to 
high dose," which was pre- 
sented at the Radiological 
Society of North America 
Annual Meeting, November 
25-30, in Chicago, Illinois. 
Eduardo Moros, PhD, 
associate professor of radia- 
tion oncology, was invited 
to serve as an ad hoc grant 
reviewer for the Radiation 
Study Section of the Onco- 
logical Sciences Integrated 
Review Group at the 
National Institutes of 
Health's Center for Scientific 
Review, San Francisco, 
California, November 2-4. 
Barry Siegel, MD, profes- 
sor of radiology and of 
medicine, and director of the 
Division of Nuclear Medi- 
cine, received a Certificate 
of Outstanding Contribution 
from the American College 
of Radiology Imaging Net- 
work (ACRIN) in recognition 
of his "contribution towards 
ACRIN achieving its goal of 
conducting high quality 
clinical trials of imaging 
technology and thereby 
improving the quality and 
length of lives of cancer 
patients." 
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Sharlene Teefey, MD, 
associate professor of radiol- 
ogy, received a $300,000 
award from the Radiological 
Society of North America's 
Research and Education 
Foundation International 
Radiology Program for 
"Teach the Teachers." The 
three-year award is designed 
to provide opportunities to 
use or develop educational 
programs for individuals in 




Samuel Achilefu, PhD, 
associate professor of radiol- 
ogy, presented "The few, the 
proud, the challenged" at 
The Optical Imaging of Brain 
Function Summer Program 
Graduation, University of 
Pennsylvania, Philadelphia, 
August 17. He spoke on "Tar- 
geting exogenous optical 
agents for tumor diagnosis 
and therapy" at the Optical 
Society of America Annual 
Meeting, Long Beach, Cali- 
fornia, October 15. 
Carolyn Anderson, PhD, 
associate professor of radiol- 
ogy and of molecular biology 
and pharmacology, pre- 
sented "Copper complexes 
as radiopharmaceuticals: 
from inorganic chemistry to 
in vivo studies" at the Uni- 
versity of Missouri, St. Louis, 
October 15, and at the Uni- 
versity of New Hampshire, 
Durham, October 23. 
Jeffrey Bradley, MD, 
instructor in radiation oncol- 
ogy, as invited speaker, pre- 
sented "It's time to focus on 
lung cancer" at a symposium 
sponsored by The Wellness 
Community of Greater 
St. Louis, Missouri, 
November 10. 
Clifford Chao, MD, assis- 
tant professor of radiation 
oncology, spoke on "IMRT 
for head and neck cancer" 
at the Southeast Missouri 
Regional Cancer Center, 
Cape Girardeau, Missouri, 
October 27. 
Thomas Conturo, MD, 
PhD, associate professor of 
radiology and adjunct pro- 
fessor of physics and of bio- 
medical engineering, 
presented "Diffusion tensor 
fiber tracking: methods, 
experimental results, and 
error simulations" at the 
Workshop on Diffusion NMR 
and MRI: From the Single 
Molecule to the Entire 
Human Brain, Tel Aviv 
University, Tel Aviv, Israel, 
August 26-30. He spoke on 
"Tracing white matter fiber 
connections with MRI and 
clinically practical whole- 
brain bolus perfusion 
imaging" at the Instituto 
Neurologica Carla Besta, 
Milan, Italy, August 31. 
Louis Gilula, MD, profes- 
sor of radiology and of 
surgery, spoke on "Unusual 
problems with vertebro- 
plasty and how to handle 
them" at the International 
Skeletal Society meeting, 
Montreal, Quebec, Septem- 
ber 5. He presented "Analy- 
sis of complex carpal 
trauma," "Ligamentous insta- 
bility of the wrist," "Wrist 
arthrography," and "Muscu- 
loskeletal CT" at the Nicer 
Course on Musculoskeletal 
Imaging, Buenos Aires, 
Argentina, October 26-28. As 
visiting professor, Gilula pre- 
sented "Ligamentous insta- 
bilities of the wrist" and 
"Wrist trauma cases - 
unknowns" at Oregon Health 
Sciences University, Port- 
land, November 16. 
Anil Khosla. MD, instructor 
in radiology, spoke on "Spine 
intervention procedures" at 
the Ninth Annual Radiology 
Update for the Clinician, 
Memorial Hospital, Carbon- 
dale, Illinois, November 3. 
Eric Klein, MS, associate 
professor of radiology, pre- 
sented "Intensity modulated 
radiation therapy," "Multileaf 
collimation: utility, dosime- 
try, and cost analysis," and 
"Dynamic wedging: utility, 
dosimetry, and cost analysis" 
at the Brazilian Radiotherapy 
Oncology Society Annual 
Meeting, Blumeneau, Brazil, 
August 20-23. 
Jason Lewis, PhD, 
research instructor in radiol- 
ogy, presented "MRI and 
microPET imaging of tumor 
progression in hamster 
abdomens following laparo- 
scopic surgery and radio- 
therapy" at the High 
Resolution Imaging in Small 
Animals: Instrumentation, 
Application and Animal Han- 
dling meeting, Rockville, 
Maryland, September 9-11. 
Jacob Locke, MD, instruc- 
tor in radiation oncology, 
spoke on "Enhancement of 
hyperthermic radiosensitiza- 
tion and inhibition of NF-kB 
with indomethacin." 
Elizabeth McFarland, MD, 
associate professor of radiol- 
ogy, presented "Tracheal 
resection and primary anas- 
tomosis: 3D imaging of tra- 
chea" at ENT Grand Round 
Washington University in 
St. Louis, Missouri, October 
24. She spoke on "Colonog- 
raphy: current issues" a the 
Turnbull Lecture Series, 
Department of Colorectal 
Surgery, Washington Univer- 
sity in St. Louis, Missouri, 
November 2. 
Robert McKinstry, MD, 
PhD, assistant professor 
of radiology, spoke on 
"Cerebral blood flow: MR 
diffusion/perfusion" at The 
2nd Annual International 
Symposium and Hands-on 
Course on Cerebral Revascu- 
larization, Saint Louis Uni- 
versity, St. Louis, Missouri, 
November 30. 
Jeff Michalski, MD, assis- 
tant professor of radiation 
oncology, presented "RTOG 
trials in the management of 
prostate cancer with 3D 
CRT" at the University of 
Chicago, Illinois, August 2. 
He presented "3D radiation 
therapy and hormone ther- 
apy in the management of 
prostate cancer - The RTOG 
trials" at Ball Memorial Hos- 
pital, Muncie, Indiana, Sep- 
tember 18. He spoke on "3-D 
CRT" at The Prostate Cancel 
Lecture Series Program, 
sponsored by IntraMed Edu- 
cation Group, New Orleans, 
Louisiana, September 19. 
Michalski spoke on "Grade 2 
toxicity on RTOG 9406: rob- 
bing Peter to pay Paul" at th< 
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on Dose, Time & Fractiona- 
tion in Radiation Oncology, 
Madison, Wisconsin, Septem- 
ber 23. He presented"3D- 
CRT/IMRT prostate" at 
Kyoto University, Kyoto, 
Japan, December 5, and par- 
ticipated in The 3911' Forum 
of Radiation Oncology, 
Chugoku-Shikoku, Japan, 
December 6. Michalski 
esented "3D conformal 
aerapy for prostate cancer" 
at Hiroshima University, 
Hiroshima, Japan, December 
7. He spoke on "An update 
on conformal RT trial con- 
ducted by the RTOG" and 
cochaired the symposium 
on "How clinical outcomes 
can be improved by 3D- 
CRT/IMRT in terms of local 
control rate and incidence 
of sequelae," sponsored by 
the Association of 3-Dimen- 
sional Conformal Radiother- 
apy, Nagoya University 
School of Medicine Nagoya, 
Japan, December 8-11. 
Barbara Monsees, MD, 
professor of radiology and 
chief of breast imaging, 
presented "Imaging in breast 
cancer" at New Imaging 
Techniques for Cancer 
Management, sponsored by 
St. Luke's Hospital, St. Louis, 
Missouri, October 16. 
Pratik Mukherjee, MD, 
PhD, clinical fellow in neu- 
roradiology, spoke on "Diffu- 
sion tensor MR imaging of 
normal human brain matura- 
tion" at the University of 
California, San Francisco 
Medical Center, San Fran- 
cisco, September 18, and 
at Stanford University 
Hospital, Stanford, 
California, September 20. 
Carlos Perez, MD, profes- 
sor of radiation oncology 
and chair of the Department 
of Radiation Oncology, pre- 
sented "Tumor physiology 
and distant spread" and 
"Functional imaging in treat- 
ment planning in radiation 
therapy" at Modern Radio- 
therapy, Tumor Physiology, 
and Functional Imaging, 
sponsored by the Instituto 
di Radiologia, Universita 
Cattolica del Sacro Cuore, 
Rome, Italy, November 
12-16. 
William Powers, MD, pro- 
fessor of neurology and of 
radiology, spoke on "Imaging 
of haemodynamics and 
metabolism in cerebrovascu- 
lar diseases" at the 11th 
Nordic Meeting on Cere- 
brovascular Diseases, Kuo- 
pio, Finland, August 12. 
William Reinus, MD, asso- 
ciate professor of radiology, 
presented "Rheumatology 
radiology rounds" at Grand 
Rounds, Department of 
Rheumatology, Washington 
University in St. Louis, 
Missouri, October 18. 
Henry Royal, MD, profes- 
sor of radiology, presented 
"Treatment of hyperthy- 
roidism with 1-131 - consen- 
sus and controversies" at 
2001 - A Functional Imaging 
Odyssey, sponsored by The 
Missouri Valley Chapter of 
The Society of Nuclear 
Medicine, Columbia, 
Missouri, October 6. 
Stuart Sagel, MD, profes- 
sor of radiology, chief of 
chest radiology, and codirec- 
tor of body computed 
tomography, spoke on "CT 
of the thorax: anatomic 
variants and pitfalls," "Inter- 
active problematic cases," 
Perez Lecture 
The First Carlos A. Perez Endowed Lectureship in Oncology, in honor of Carlos 
Perez, MD, professor of radiation oncology and chairman of the Department of 
Radiation Oncology, was held on December 7. Norman Coleman, MD, director of 
the radiation oncology sciences program, associate director of the radiation 
research program, and deputy director of the Division of Clinical Sciences at the 
National Cancer Institute, National Institutes of Health, presented "Radiation oncol- 
ogy and the NCI's extraordinary opportunities: molecular imaging, signatures, and 
therapeutics." William Peck, MD, executive vice chancellor for medical affairs and 
dean of the School of Medicine, is shown with the commemorative plaque pre- 
sented to Coleman (second from left). Also shown are Perez (far right) and Todd 
Wasserman, MD, chief, Clinical Division, Department of Radiation Oncology. 
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"Role of CT in bronchogenic 
carcinoma," "CT of the peri- 
cardium," and "CT of non- 
vascular mediastinal masses" 
at the 11th Summer 
Practicum of the Society 
of Computed Body Tom 
ography and Magnetic 
Resonance, Keystone, 
Colorado, August 20-24. 
Vijay Sharma, PhD, assis- 
tant professor of radiology, 
as invited speaker, presented 
"Targeting chloroquine- 
resistant Plasmodium 
Falciparum with novel 
antimalarial metal(III) 
complexes: structure-activity 
relationships" at the Medici- 
nal Chemistry Symposium 
of the 222'"' National Meeting 
of the American Chemical 




Barry Siegel, MD, profes- 
sor of radiology and of medi- 
cine, and director of the 
Division of Nuclear Medi- 
cine, as the Eighth Annual 
Ralph G. Robinson, MD 
Memorial Lecturer, spoke on 
"Oncologic FDG-PET - arti- 
facts, variants, and benign 
lesions simulating cancer" at 
2001 - A Functional Imaging 
Odyssey, sponsored by The 
Missouri Valley Chapter of 
The Society of Nuclear Medi- 
cine, Columbia, Missouri, 
October 6. He presented 
"FDG-PET in oncology" at 
the Annual Meeting and 
Scientific Session of the 
Oklahoma Society of Clinical 
Oncology, Tulsa, Oklahoma, 
October 12 and 13. He spoke 
on "Clinical applications of 
PET in oncology" at New 
Imaging Techniques for 
At the Thirtieth 
Annual Wendell 
G. Scott Memo- 





PhD, professor of radiology and of molecular biology 
and pharmacology, spoke on "Radiology in the post- 
genome era: new frontiers in molecular imaging." 
Cancer Management, spon- 
sored by St. Luke's Hospital, 
St. Louis, Missouri, October 
16. Siegel presented "Evalu- 
ating tumor response to 
treatment with FDG PET" 
and "PET: techniques, arti- 
facts, and interpretations" 
at the Fifteenth Annual 
Northeast Regional Scientific 
Meeting of the Society of 
Nuclear Medicine, Greater 
New York and New England 
Chapters, Stamford, Con- 
necticut, October 26-28. As 
guest lecturer, he presented 
"PET Imaging" at The Sec- 
ond Annual John H. Walker, 
MD Lecture in Radiology, 
Virginia Mason Medical Cen- 
ter, Seattle, Washington, 
November 2. He spoke 
on"Assessing tumor biology 
with PET" and "Clinical 
applications of PET scanning 
in oncology" at Modern 
Radiotherapy, Tumor Physi- 
ology, and Functional Imag- 
ing, sponsored by the 
Instituto di Radiologia, Uni- 
versita Cattolica del Sacro 
Cuore, Rome, Italy, Novem- 
ber 12-16. 
Marilyn Siegel, MD, 
professor of radiology and 
of pediatrics, presented 
"Pediatric mediastinal 
masses," "Pediatric renal 
masses: multimodality imag- 
ing strategies," "Adrenal and 
retroperitoneal masses in 
children," and "Pediatric 
liver masses: CT/MRI" at the 
14,h Jornada Gaucha de Radi- 
ologia meeting, Gramado, 
Brazil, August 17-19. As an 
invited guest speaker, she 
presented "CT and MRI of 
pediatric renal masses" at 
the Pediatric Update 2001, 
Toronto, Ontario, September 
8. Siegel spoke on "Fast MR 
imaging of small cell tumors" 
at the Children's Oncology 
Group meeting, San Antonio, 
Texas, October 18. She pre- 
sented "MRI imaging of bone 
marrow" and "Imaging of 
common abdominal tumors 
in children" at Modern 
Radiotherapy, Tumor 
Physiology, and Functional 
Imaging, sponsored by the 
Instituto di Radiologia, 
Universita Cattolica del 
Sacro Cuore, Rome, Italy, 
November 12-16. 
Sheng-Kwei Song, PhD, 
instructor in radiology, 
spoke on "Detection of white 
matter tracts in mouse brain 
and spinal cord" at the High 
Resolution Imaging in Small 
Animals: Instrumentation, 
Application and Animal Han- 
dling meeting, Rockville, 
Maryland, September 9-11. 
Todd Wasserman, MD, 
professor of radiation oncol- 
ogy, presented "The role of 
radiation in the treatment 
of lymphomas" at the 
Annual Meeting and Scien- 
tific Session of the Okla- 
homa Society of Clinical 
Oncology, Tulsa, Oklahoma, 
October 12 and 13. 
Dmitriy Yablonskiy, PhD, 
assistant professor of radiol- 
ogy, spoke on "Human brain 
temperature regulation and 
oxidative metabolism during 
functional visual stimula- 
tion" at the International 
Thermal Physiology Sympo- 
sium, Wollongong, Australia, 
September 4. As invited lec- 
turer, he presented "The rok 
of tissue-specific magnetic 
susceptibility effects in MR 
signal formation: theoretical 
concepts and experimental 
applications" to the 
Department of Radiology, 
Evanston Northwestern 
Healthcare, Chicago, Illinois 
November 30. 
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In this section ofFYI, only 
'hose faculty and staff 
who have Department of 
Radiology or Department 
of Radiation Oncology 
appointments are listed. 
AMERICAN SOCIETY FOR 
THERAPEUTIC RADIOL- 
OGY AND ONCOLOGY 
43rd Annual Meeting 
San Francisco, California 
November 4 - 8, 2001 
Jeffrey Bradley, MD, 
recipient of a 2001 European 
Society for Therapeutic 
Radiology and Oncology 
Travel Grant. 
V0RKSH0P ON PHYSICS 
EACHING TO RADIATION 
ONCOLOGY RESIDENTS 
Eric Klein, MS, "The 
variation of physics teaching 
material and intensity 
among programs." 
REFRESHER COURSE 
Sasa Mutic, MS, "CT 
simulation process and 
techniques." 
SCIENTIFIC SESSIONS 
Angel Blanco, MD; James 
Dempsey, PhD; Clifford 
Chao, MD, "A scoring 
function for target coverage 
in intensity modulated 
radiation therapy (IMRT) 
planning based on the proba- 
bility of microscopic tumor 
extension and lymph node 
metastasis." 
Clifford Chao, MD; Walter 
Bosch, DSc; Sasa Mutic, 
MS; Jason Lewis, PhD; 
Farrokh Dehdashti, MD; 
Mark Mintun, MD; James 
Dempsey, PhD; Carlos 
Perez, MD; James Purdy, 
PhD; Michael Welch, PhD, 
"A prospective study on 
tumor hypoxia kinetics to 
implement hypoxic imaging- 
guided IMRT." 
James Dempsey, PhD; 
Joseph Deasy, PhD; 
Walter Bosch, DSc; 
Daniel Low, PhD, "Treat- 
ment plan review tools 
incorporating spatial 
dose-volume information." 
Perry Grigsby, MD, "Long- 
term follow-up of RTOG 
88-05: twice daily external 
irradiation with brachyther- 
apy for carcinoma of the 
cervix." 
Jeff Michalski, MD; Feng- 
ming Kong, MD; David 
Mansur, MD; Carlos 
Perez, MD, "Quality of life 
following 3D conformal radi- 
ation therapy or permanent 
interstitial brachytherapy for 
localized prostate cancer." 
Binh Tran, MD; Clifford 
Chao, MD; James 
Dempsey, PhD, "Patterns of 
local regional failure in head 
and neck cancer treated with 
IMRT." 
POSTER PRESENTATIONS 
Joseph Deasy, PhD; 
Joseph Roti Roti, PhD; 
Daniel Low, PhD, "Dose- 
rate effects in intensity mod- 
ulated radiation therapy." 
Perry Grigsby, MD; Far- 
rokh Dehdashti, MD; Tom 
Miller, MD, PhD; Barry 
Siegel, MD, "FDG-PET eval- 
uation of tumor control after 
radiotherapy for carcinoma 
of the uterine cervix." 
Clifford Chao, MD; Chih- 
Jen Huang, MD; Joseph 
Simpson, PhD, MD; Carlos 
Perez, MD, "Intensity-mod- 
ulated radiation therapy 
yields satisfactory tumor 
control and spares salivary 
function in patients with 
oropharyngeal carcinoma: 
a nonrandomized compari- 
son with conventional 
techniques." 
Shervin Karimpour, MD, 
"Active site cysteine residues 
in thioredoxin reductase reg- 
ulate cell cycle progression 
and NF-kB activity." 
Clifford Chao, MD, "Lym- 
phangiogram-assisted lymph 
node target delineation for 
patients with gynecological 
malignancies receiving IMRT 
treatment." 
Xiao Lin, MD, PhD, "2- 
deoxy-d-glucose is a cyto- 
toxic and radiosensitizing 
agent in tumor cells." 
Daniel Low, PhD; Jeffrey 
Bradley, MD; Joseph 
Deasy, PhD; Richard 
Laforest, PhD; Jason 
Sohn, PhD; Farrokh 
Dehdashti, MD; Sasa 
Mutic, MS; Walter Bosch, 
DSc, "Lung trajectory 
mapping." 
Robert Malyapa, MD, PhD; 
Clifford Chao, MD; Jef- 
frey Williamson, PhD; 
Perry Grigsby, MD, "Pelvic 
organ motion and displace- 
ment during radiation 
therapy in patients with 
gynecological malignancies - 
a prospective study 
using serial CT imaging 
during external-beam 
radiotherapy." 
David Mansur, MD; Feng- 
ming Kong, MD; Eric 
Klein, MS; Jeffrey 
Bradley, MD; Marie Tay- 
lor, MD; Carlos Perez, 
MD; Harvey Glazer, MD; 
Imran Zoberi, MD; Robert 
Myerson, PhD, MD, "Three 
dimensional localization of 
internal mammary and axil- 
lary lymphatic regions and 
the significance on opti- 
mized breast cancer treat- 
ment planning." 
Tom Miller, MD, PhD; 
Perry Grigsby, MD, "Mea- 
surement of tumor volume 
by PET to evaluate progno- 
sis in patients with cervical 
cancer." 
Anurag Singh, MD; Mary 
Ann Lockett, MBA; Jef- 
frey Bradley, MD, "Analy- 
sis of clinical and dosimetric 
predictors of radiation- 
induced esophageal toxicity 
in patients with non-small 
cell lung cancer treated with 
three dimensional conformal 
radiation therapy." 
Jason Sohn, PhD; Daniel 
Low, PhD; Joseph Deasy, 
PhD, "Motion-induced dose 
distribution artifacts in lung 
cancer IMRT." 
Jeffrey Williamson, PhD; 
Fritz Lerma, PhD; Clifford 
Chao, MD; Kyongtae Bae, 
MD, PhD; Kim Nguyen, 
dosimetry QA specialist; 
Perry Grigsby, MD; John 
Matthews, DSc, "3D image- 
based dose planning of intra- 
cavitary brachytherapy and 
teletherapy of gynecological 
tumors: registration of cumu- 
lative dose via deformable 
anatomic templates." 
FOCAL SPOT, FALL/WINTER 2001 2'. I 
SYMPOSIA 
Continued from page 29 
SOCIETY FOR 
NEUROSCIENCE 
31st Annual Meeting 
San Diego, California 
November 10-15, 2001 
ORAL PRESENTATIONS 
Kevin Black, MD; Joel 
Perlmutter, MD, "Parkin- 
son's disease patients with 
levodopa-related mood fluc- 
tuations have increased pos- 
terior cingulate response to 
acute levodopa." 
Harold Burton, PhD; 
Abraham Snyder, MD, 
PhD; Thomas Conturo, 
MD, PhD; Erbil Akbudak, 
PhD; John Ollinger, DSc; 
Marcus Raichle, MD, "A 
fMRI study of verb genera- 
tion to heard nouns in early 
and late blind." 
Marcus Raichle, MD; 
Harold Burton, PhD; 
Abraham Snyder, MD, 
PhD; Erbil Akbudak, PhD; 
Thomas Conturo, MD, 
PhD, "Negative BOLD 
responses in early and late 
blind." 
POSTER PRESENTATIONS 
Erbil Akbudak, PhD; 
Joshua Shimony, MD, 
PhD; Abraham Snyder, 
MD, PhD; Marcus 
Raichele, MD; Harold Bur- 
ton, PhD; Thomas Con- 
turo, MD, PhD, "Diffusion 
MRI tracking of amygdalo- 
calcarine pathways: 












PhD, director of 
the program in cancer biology at Stanford University, 
spoke on "Identification of mechanisms of action of 
anticancer agents using yeast genomics." 
Melanie Leitner, PhD; 
Abraham Snyder, MD, 
PhD; Aaron Tansy; Steven 
Petersen, PhD; Maurizio 
Corbetta, MD, "Brain reor- 
ganization in frontal aphasia: 
a longitudinal study." 
Stephen Moerlein, PhD; 
Michael Welch, PhD; Joel 
Perlmutter, MD, "PET 
imaging of the serotonin S3 
antagonist [C-ll] 
ondansetron in living baboon 
brain." 
Joel Perlmutter, MD; 
Stephen Moerlein, PhD; 
Michael Welch, PhD, 
"Imaging studies of [C-ll] 
(N-methyl) benperidol 
(NMB) as a D2 receptor- 
binding PET tracer." 
Abraham Snyder, MD, 
PhD; Kevin Black, MD; 
Mokhtar Gado, MD; Joel 
Perlmutter, MD, "MRI and 
PET template images for 
neuroimaging in baboon and 
macaque." 
RADIOLOGICAL SOCIETY 
OF NORTH AMERICA 
87th Scientific Assembly 
and Annual Meeting 
Chicago, Elinois 
November 25 - 30, 2001 
Kyongtae Bae, MD, PhD, 
presiding officer, Gastroin- 
testinal (CT liver, contrast 
techniques). 
Dennis Balfe, MD, presid- 
ing officer, Gastrointestinal 
(intervention, upper gas- 
trointestinal tract); presiding 
officer, Gastrointestinal (CT: 
pancreatitis). 
Fengming Kong, MD, PhD, 
recipient of RSNA Resident 
Research Trainee Prize - 
2001. 
Louis Gilula, MD, presiding 
officer, Musculoskeletal 
(infection). 
Jay Heiken, MD, member 
Program Committee: 
gastrointestinal radiology; 
presiding officer, Gastroin- 
testinal (pancreatic cancer: 
CT and MR); Gastrointestinal 
keynote speaker. 
Gilbert Jost, MD, modera- 
tor, IHE Symposium: Inte- 
grating the Healthcare 
Enterprise: clinical goals and 
technical challenges. 
Jeff Michalski, MD, mem- 
ber, Program Committee: 
radiation oncology and 
radiobiology; presiding offi- 
cer, Radiation Oncology 
(prostate: brachytherapy). 
Barbara Monsees, MD, 
guest lecturer, "Update on 
breast imaging." 
Srinivasa Prasad, MD, 
recipient of RSNA Research 
Trainee Prize - 2001. 
Marilyn Siegel, MD, mod 
erator, Friday Imaging 
Symposium, "Screening foi 
cancer"; member, Refreshei 
Course Committee. 
Sharlene Teefey, MD, pre- 
siding officer, Ultrasound 
(musculoskeletal). 
REFRESHER COURSES 
Dennis Balfe, MD, "Imag- 
ing the invisible: mesenteries 
and peritoneum of the upper 
abdomen." 
Sanjeev BhaUa, MD, "Air- 
ways: virtual and dynamic 
imaging." 
Louis Gilula, MD, coordi- 
nator, "Vertebroplasty: 
indications, technique, prob- 
lems, and complications." 
' 
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Fernando Gutierrez, MD, 
"Vascular anomalies: medi- 
Tf astinum and lung." 
\y Heiken, MD, "Imaging 
focal liver lesions with CT 
Kid MR." 
David Hovsepian, MD, 
i "Hysterosalpingography and 
[selective salpingography 
|('how-to' workshop)." 
■ Daniel Low, PhD, "Physics 
I of three-dimensional confor- 
Imal radiation therapy and 
intensity-modulated radia- 
tion therapy." 
Elizabeth McFarland, MD, 
'CT of the small bowel and 
colon: principles, techniques, 
and applications." 
Jeff Michalski, MD, "Dose 
escalation with three-dimen- 
sional conformal radiation 
therapy." 




David Rubin, MD, "Ankle 
MR imaging: techniques, nor- 
mal anatomy, and common 
pathology-an interactive ses- 
sion." 
Barry Siegel, MD, modera- 
tor, "Optimizing PET inter- 
pretation"; "Pediatric MR 
imaging—an interactive ses- 
sion: abdomen." 
Marilyn Siegel, MD, "Focal 
hepatic masses." 
Sharlene Teefey, MD, 
"Practical tips in US: muscu- 
loskeletal - hand and wrist"; 
"Musculoskeletal US ('hands- 
on workshop')-" 
SCIENTIFIC EXHIBITS 
Sanjeev Bhalla, MD; 
Christine Menias, MD, 
"Radiologic-pathologic cor- 
relation of abdominal 
masses tha tmay present as 
life-threatening hemor- 
rhage." 
Sanjeev Bhalla, MD; 
Premsri Barton, MD; Den- 
nis Balfe, MD, "Fat-con- 
taining lesions in the breast, 
chest, and abdomen: friends 
or foe?" 
Carol Hwang, MD; Prem- 
sri Barton, MD: Barbara 
Monsees, MD; Dione Far- 
ria, MD, MPH; Thomas 
Pilgram, PhD, "Breast can- 
cer Tl tumor size: correla- 
tion of mammography, 
ultrasound, and pathologic 
measurements." 
Christine Menias, MD, 
"Volvulus above and below 
the diaphragm." 
Probstein Lecture 
Eric Klein, MD, associate profes- 
sor of surgery, Ohio State Univer- 
sity, and head of urologic 
oncology, The Cleveland Clinic, 
presented the Norman K. Prob- 
stein Oncology Lecture on Octo- 
ber 23. The lecture topic was 
"Localized prostate cancer surgery 
or radiation therapy: the debate 
continues." 
Pratik Mukherjee, MD; 
Joseph Philip, MD; Ben- 
jamin Lee, MD; Jeffrey 
Neil, MD, PhD; Robert 
McKinstry, MD, PhD, "Dif- 
fusion-tensor MR imaging of 
normal human brain matura- 
tion: a pictorial essay." 
Mehdi Poustchi-Amin, 
MD; Jeffrey Brown, MD; 
Kezaei Kianoush, MD; 
Thelma Lopes, MD; 
Edward Lee, MD, "Practi- 
cal MRI of the body: princi- 
ples, applications, and 
protocols-a review for the 
general radiologist." 
SCIENTIFIC SESSIONS 
Douglas Adkisson, BS; 
Erbil Akbudal, PhD; 
Joshua Shimony, MD, 
PhD; Thomas Conturo, 
MD, PhD, "Finite-element 
analysis of the magnetic 
field effects of compartmen- 
talized paramagnetic 
agents." 
Erbil Akbudak, PhD; 
Melanie Kotys, MS; 
Glenn Foster, RT; Joanne 
Markham, MS; Thomas 
Conturo, MD, PhD, "Whole- 
brain bolus perfusion imaging 
in humans with a head-only 3 
Tesla MRI system." 
Kyongtae Bae, MD, PhD, 
"MR imaging to assess the 
progression of polycystic 
kidney disease: work in 
progress." 
Kyongtae Bae, MD, PhD; 
Paul Commean, BEE; 
Jeong Rim Lee, PhD; 
Jongdae Suh, MD; Barry 
Brunsden, "Development of 
image analysis method for 
volumetric measurement of 
renal cysts and parenchyma 
using MRI." 
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Kyongtae Bae, MD, PhD; 
Jay Heiken, MD; Huy 
Tran, MD; Sheila Agan, 
research patient, coordinator, 
"Uniform vascular contrast- 
enhancement and reduced 
contrast volume achieved by 
multiphasic injection 
method: clinical validation." 
Kyongtae Bae, MD, PhD; 
Jongdae Suh, MD; Bruce 
Whiting, PhD, "3D visual- 
ization of cochlea using high- 
resolution CT for cochlear 
implant surgery planning." 
Kyongtae Bae, MD, PhD, 
"Coronary scoring using 
multi-slice CT: evaluation of 
interscan variability and 
optimal scan tube current." 
Jeffrey Bradley, MD; 
Wade Thorstad, MD; Sasa 
Mutic, MS; Jennifer Britt, 
dosimetry QA specialist; 
Walter Bosch, DSc, "Image- 
guided radiotherapy using 
PET/CT fusion improves 
delineation of target volumes 
and alters the three-dimen- 
sional radiotherapy plan 
in non-small cell lung 
carcinomas." 
Louis Gilula, MD, "Differ- 
ent types of polymethyl- 
methacrylate (PMMA) 
leakage as short- and 
mid-term predictors for 
patient symptoms in 363 
vertebroplasties." 
Fengming Kong, MD; Eric 
Klein, MS; Jeffrey 
Bradley, MD; David 
Mansur, MD; Marie Tay- 
lor, MD; Carlos Perez, 
MD, "Analysis of lung and 
heart dose to decipher cen- 
tral lung/maximal heart dis- 
tances and radiation 
techniques for intact breast 
irradiation." 
Jason Leawoods, MS: 
Dmitriy Yablonskiy, PhD; 
David Gierada, MD; Mark 
Conradi, PhD, "Comparison 
of 3He MR images of gas dif- 
fusion and ventilation in the 
lungs of candidates for lung 
volume reduction surgery 
(LVRS)." 
Margaret Lee, MD; Bar- 
bara Monsees, MD; Kim- 
berly Wiele, MD; Premsri 
Barton, MD, "Ultrasound 
breast biopsy: number of 
cores obtained in routine 
practice." 
Jacob Locke, MD, Risk fac- 
tors for acute urinary reten- 
tion requiring temporary 
intermittent catherization 
after prostate brachytherapy: 
a prospective study." 
Thelma Lopes, MD; 
William Reinus, MD, 
"Acetabular labral tear: MRI 
arthrography findings and 
arthroscopic correlation." 
Ronan McDermott, 
MBBCh; Elizabeth McFar- 
land, MD; Christine 
Menias, MD, "Prospective 
comparison of air and C02 
insufflation techniques at CT 
colonography: evaluation of 
image quality and patient 
reactions." 
Barbara Monsees, MD; 
Dione Farria, MD, MPH, 
"Training and attitudes of 
residents regarding breast 
imaging." 
Christopher Moran, MD; 
Colin Derdeyn, MD; 
DeWitte Cross, MD, "Mag- 
netic-tipped guidewire- 
catheter manipulation in 
patients with intracranial 
aneurysms." 
Robert Myerson, PhD, 
MD; Mary Ann Lockett, 
MBA, "The addition of con- 
tinuous infusion 5-FU to pre- 
operative radiotherapy 
increases sphincter in 
locally-advanced low-rectal 
cancer." 
Vikram Patel, MD; William 
Middleton, MD: Sharlene 
Teefey, MD, "Giant cell 
tumors of the tendon sheath: 
analysis of sonographic 
features." 
Srinivasa Prasad, MD, "CT 
tumor measurement and 
assessment of tumor 
response: unidimensional, 
bidimensional, and volumet- 
ric techniques - Is there an 
optimal technique?"; "Com- 
parison between standard 
dose and 50%-reduced dose 
abdominal CT: effect on 
image quality." 
Joshua Shimony, MD, 
PhD; Erbil Akbudak, PhD; 
Thomas Conturo, MD, 
PhD, "Diffusion and perfu- 
sion imaging of the cervical 
spinal cord." 
Bruce Whiting, PhD; 
Kyongtae Bae, MD, PhD, 
"Three-dimensional localiza- 
tion of cochlear implants by 
co-registration of CT and 
radiograph images." 
Dmitriy Yablonskiy, PhD; 
Joseph Ackerman, PhD, 
"Liver-fat content quantifica- 
tion by MR spectroscopy 
in patients with apoB 
truncation-containing 
lipoproteins." 
Dmitriy Yablonskiy, PhD; 
Michelle Lee, BS; Jason 
Leawoods, MS; David 
Gierada, MD; Mark Con- 
radi, PhD, "3He diffusional 
MRI provides quantitative 
information on lung tissue 
structure in patients with 
emphysema." 
Jie Zheng, PhD; Jason 
Leawoods, MS; Mark 
Nolte, special procedures 
technologist; Dmitriy 
Yablonskiy, PhD; Mark 
Conradi, PhD, "MR volu- 
metric pulmonary artery per- 
fusion, angiography, and 3He 
lung ventilation imaging: ini- 
tial experience." 
IHE SYMPOSIUM 
Gilbert Jost, MD, "Clinical 




In the summer 2001 issue of 
Focal Spot magazine, Maria 
Schmidt, MD, assistant pro- 
fessor of radiology, was 
incorrectly listed as the 
recipient of a $25,000 grant 
from the Alvin J. Siteman 
Cancer Center. Dione Farria, 
MD, assistant professor of 
radiology, should have been 
listed as principal investiga 
tor for the Siteman-funded 
study on "Evaluating the 
effect of informed consent 
and procedure scheduling oi 
breast biopsy patient out- 
comes." Schmidt, along witli 
Mark Walker, PhD, Depart- 
ment of Medicine, is a co- 
investigator. Consultant is 
Jill Bokern, RN, Barnes- 
Jewish Hospital. 
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To Our Physician Colleagues 
When you're trying to schedule a patient for a CT or an MRI exam, 
it pays to know your options. Barnes-Jewish West County Hospital 
(BJWCH) now has on line a second CT and a second MRI—both 
state-of-the-art technology. This assures that your patients receive 
the studies they need as soon as possible. 
Head, spine, musculoskeletal, and abdomen CT and MRI as well as 
general X rays are offered through the Barnes-Jewish West County 
Hospital Imaging Center. You can be assured your patients will receive 
professional care from our expert staff of board-certified radiologists, 
each a member of the renowned Mallinckrodt Institute of Radiology at 
Washington University. Additionally, the images can be electronically 
transmitted to Barnes-Jewish Hospital for review on the Picture 
Archiving System (PACS). 
The facility is easily accessible with plenty of free parking. 
Call (314) 996-8080 to schedule an appointment. 
Barnes-Jewish 
West County Hospital 
"OH Healthcare" 
S Washington 
University in St. IDUJS 
SCHOOL OF MEDICINE 
1%/IID Mallinckrodt Institute 
1 Tim of Radiology 
Washington 
University in StLouis 
SCHOOL OF MEDICINE 
I \i I f [J Mallinckrodt Institute 
I /III i of Radiology 
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